Avinger reports third quarter 2024 results

Lower operating cost profile drives improved productivity, increased gross margin redwood city, ca / accesswire / november 7, 2024 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the third quarter ended september 30, 2024. third quarter and recent highlights reported third quarter 2024 revenue of $1.7 million, sequentially increased gross margin to 26%.
AVGR Ratings Summary
AVGR Quant Ranking